Cardiovascular risk and glycemic control
- 27 April 2009
- journal article
- comment
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 180 (9), 907-908
- https://doi.org/10.1503/cmaj.090252
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Effect of interactions between C peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitusCMAJ : Canadian Medical Association Journal, 2009
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesThe New England Journal of Medicine, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesThe New England Journal of Medicine, 2005
- Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2003
- Insulin Resistance and Cardiovascular DiseaseJournal of Clinical Endocrinology & Metabolism, 2001
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998